You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 9, March 1, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CLINICAL INVESTIGATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Increased Cimetidine Clearance in Burn Patients

J. A. Jeevendra Martyn, MD; David J. Greenblatt, MD; Darrell R. Abernethy, MD, PhD

JAMA. 1985;253(9):1288-1291.


Abstract

To determine the etiology of the decreased efficacy of cimetidine in burned and critically ill surgical patients, we studied the kinetics and dynamics of the drug in eight burned patients at a mean of 12 days after the burn. The kinetics were compared with those of nine healthy controls. The elimination half-life of cimetidine in burned patients was significantly reduced (2.2 v 1.5 hours), and total clearance significantly increased (8.2 v 13.3 mL/min/kg). Creatinine and total cimetidine clearance were highly correlated with size of the burn. In the patients studied, 63% of the dose was excreted in eight hours, compared with 45% after 24 hours in controls. Gastric pH was maintained at 4 or higher as long as plasma levels of cimetidine were held above 0.5 µg/mL. Thus, the increased clearance of cimetidine might explain the decreased effectiveness of this drug in burned and possibly other surgical patients. Dose schedules may need to be altered to compensate for the enhanced clearance of this drug.

(JAMA 1985;253:1288-1291)



Author Affiliations

From the Department of Anesthesiology, Harvard Medical School, and the Anesthesia Services, Massachusetts General Hospital (Dr Martyn), and the Division of Clinical Pharmacology, Tufts-New England Medical Center (Dr Greenblatt), Boston; and the Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston (Dr Abernethy).


Footnotes

Reprint requests to Department of Anesthesiology, Massachusetts General Hospital, Boston, MA 02114 (Dr Martyn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Propofol Clearance and Volume of Distribution Are Increased in Patients With Major Burns
Han et al.
J Clin Pharmacol 2009;49:768-772.
ABSTRACT | FULL TEXT  

Fentanyl Clearance and Volume of Distribution Are Increased in Patients With Major Burns
Han et al.
J Clin Pharmacol 2007;47:674-680.
ABSTRACT | FULL TEXT  

Neuromuscular Pharmacodynamics of Rocuronium in Patients with Major Burns
Han et al.
Anesth. Analg. 2004;99:386-392.
ABSTRACT | FULL TEXT  

Cimetidine in Burned Patients
Myerson
JAMA 1985;254:2559-2560.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.